Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.

A federal judge's ruling essentially blocks compound pharmacies from selling less-expensive, unapproved versions of Ozempic ...

Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...